Provided by Tiger Trade Technology Pte. Ltd.

CG Oncology Inc.

72.44
+0.44000.61%
Volume:403.87K
Turnover:29.45M
Market Cap:6.42B
PE:-26.60
High:75.00
Open:72.82
Low:71.53
Close:72.00
52wk High:80.97
52wk Low:32.57
Shares:88.64M
Float Shares:64.73M
Volume Ratio:1.28
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7235
EPS(LYR):-2.0826
ROE:-26.41%
ROA:-17.67%
PB:6.24
PE(LYR):-34.78

Loading ...

CG Oncology CEO Joins Cantor Fitzgerald Global Healthcare Conference Fireside Chat

Reuters
·
Sep 02

CG Oncology to Present at Upcoming Investor Conferences in September

GlobeNewswire
·
Sep 02

UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)

TIPRANKS
·
Aug 20

CG Oncology Director Leonard Post Disposes of USD 74,540 in Common Shares

Reuters
·
Aug 19

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
Aug 13

CG Oncology Price Target Raised to $85.00/Share from $82.00 by Truist Securities

Dow Jones
·
Aug 07

RBC Adjusts PT on CG Oncology to $79 From $81, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 07

Zentalis Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 07

Analysts’ Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)

TIPRANKS
·
Aug 07

TriSalus Life Sciences Q2 Revenue Beats Estimates

Reuters
·
Aug 07

Biopharma Firm IN8bio's Q2 Net Loss Narrows as Expenses Decline

Reuters
·
Aug 07

CG Oncology, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

CG Oncology Publishes Investor Deck Highlighting Cretostimogene Data in High-Risk NMIBC Programs

Reuters
·
Aug 06

CG Oncology Q2 EPS $(0.90) Misses $(0.67) Estimate, Sales $1.157M Beat $360.417K Estimate

Benzinga Earnings
·
Aug 06

CG Oncology Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Aug 06

Earnings Flash (CGON) CG Oncology Posts Q2 Net Loss $0.90 a Share, vs. FactSet Est of $0.66 Loss

MT Newswires Live
·
Aug 06

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

THOMSON REUTERS
·
Aug 06

CG Oncology Q2 EPS USD -0.9

THOMSON REUTERS
·
Aug 06

CG Oncology Inc - Files for Offering of up to $500 Mln Common Stock - SEC Filing

THOMSON REUTERS
·
Aug 06

Health Rounds: Experimental Cell Therapy Slows Heart Failure Progression in Duchenne Muscular Dystrophy

Reuters
·
Jul 31